The workplace project – putting learning into practice

We want our education to be impactful, transforming an individual's practice - and through that, the team or service they work within. Intermodule projects are a core part of the education we offer, providing an opportunity to reinforce learning, test new knowledge and skills and improve local services.

Attendees have free reign over their project which must meet a local need, and they present their work back to their peers at module two of the course, and the class chooses a winning project.

We believe that one of the best ways to learn something is from others who have already learned it. We'd encourage you to have a look through the extensive 'back catalogue' of previous projects to find one addressing a similar need to the one in your area, or to learn how others have overcome obstacles you might face.

'Workplace projects give a space for the MasterClass's challenging learning outcomes to change things at a grassroots level and then to keep changing them - and this is what makes a difference to people with Parkinson’s.’
Dr Peter Fletcher, academic director emeritus, Parkinson's Academy


Spotlight projects


Siponimod use in Northern Ireland
By Conor Hughes, Clinical fellow, Royal Victoria Hospital
Empowering health visitors: maximizing SMA recognition, referral, and treatment outcomes through educational initiative
By Dr Ushma Patel. clinical fellow in paediatric neurology, University Hospitals of Leicester NHS Trust & Yvonne Julien, neuromuscular care advisor, University Hospitals of Leicester NHS Trust
Development of a frailty memory service
By Dr Michelle McCarthy, Consultant community geriatrician, Countess Of Chester Hospital NHS Foundation Trust

All projects


Showing 81-90 of 107 projects

The length of time it takes to start on a DMT after diagnosis in Glasgow
By Pauline McDonald, MS Specialist Nurse, Queen Elizabeth University Hospital
PD Medication Audit
By Dr Aamer Ahmed, Consultant Geritrician, George Elliot Hospital
Early monitoring of B cells on Ocrelizumab may help to identify those at risk of adverse effects
By Chandni Radia, Lead Pharmacist Neurosciences, Imperial College Healthcare NHS Trust
Trends in drug use in the PD clinic at the RVH, Edinburgh
By Dr John Cordina, Consultant Geriatrician, Karin Grech Hospital
Review of Parkinson’s patients on dopamine agonist agents
By Dr Elizabeth Castaneda-Caicedo, Speciality Doctor, Great Western Hospital
Dopamine Agonist Monitoring
By Belinda Kessel, Parkinson's Specialist and Geriatrician, Princess Royal Hospital, University Hospital Farnborough
Prescribing and administering Parkinson’s disease drugs in patients with hip fractures: re-audit
By A. Chatterjee, R. Ganapathy, J. Bowen, S. Logan, Royal Berkshire NHS Foundation Trust